Mast cells in lung homeostasis: Beyond type I hypersensitivity

Current Respiratory Medicine Reviews

Volumn 10, Issue 2, 2014, Pages 115-123

  Campillo Navarro, Marcia ^a   Chávez Blanco, Alma D ^b   Wong Baeza, Isabel ^a   Serafín López, Jeanet ^a   Flores Mejía, Raúl ^a   Estrada Parra, Sergio ^a   Estrada García, Iris ^a   Chacón Salinas, Rommel ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Allergic inflammation; Cancer; Lungs; Mast cells; Pathogens; Wound healing

Indexed keywords

FIBROBLAST GROWTH FACTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; SCAVENGER RECEPTOR; TOLL LIKE RECEPTOR; VASCULOTROPIN;

ALLERGIC AIRWAY INFLAMMATION; ARTICLE; ASTHMA; CELL PROLIFERATION; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; INNATE IMMUNITY; LUNG CANCER; LUNG FUNCTION; LUNG INFECTION; MAST CELL; MAST CELL DEGRANULATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TYPE I HYPERSENSITIVITY; WOUND HEALING;

EID: 84930901660     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/1573398X10666141024220151     Document Type: Article

References (99)

1. [1] Crivellato E, Beltrami C, Maliardi F, Ribatti D. Paul Ehrlich's doctoral thesis: a milestone in the study of mast cells. Br J Haematol 2003; 123(1): 19-21.
2. [2] Maurer M, Theoharides T, Granstein RD, et al. What is the physiological function of mast cells? Exp Dermatol 2003; 12(6): 886-910.
3. [3] Nakano T, Sonoda T, Hayashi C, et al. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 1985; 162(3): 1025-43.
4. [4] Abraham SN, St John AL. Mast cell-orchestrated immunity to pathogens. Nat Rev Immunol. 2010; 10(6): 440-52.
5. [5] Yong LC. The mast cell: origin, morphology, distribution, and function. Exp Toxicol Pathol 1997; 49(6): 409-24.
6. [6] Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997; 77(4): 1033-79.
7. [7] Di Nardo A, Vitiello A, Gallo RL. Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide. J Immunol 2003; 170(5): 2274-8.
8. [8] Riley JF, West GB. The presence of histamine in tissue mast cells. J Physiol 1953; 120(4): 528-37.
9. [9] Kawakami T, Galli SJ. Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol. 2002; 2(10): 773-786.
10. [10] Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008; 454(7203): 445-54.
11. [11] Crivellato E, Ribatti D. The mast cell: an evolutionary perspective. Biol Rev Camb Philos Soc 2010; 85(2): 347-60.
12. [12] Jeannin P, Jaillon S, Delneste Y. Pattern recognition receptors in the immune response against dying cells. Curr Opin Immunol. 2008; 20(5): 530-7.
13. [13] Guthmann MD, Tal M, Pecht I. A new member of the C-type lectin family is a modulator of the mast cell secretory response. Int Arch Allergy Immunol 1995; 107(1-3): 82-6.
14. [14] Ribbing C, Engblom C, Lappalainen J, et al. Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression. Allergy. 2011; 66(1): 110-9.
15. [15] Yang Z, Marshall JS. Zymosan treatment of mouse mast cells enhances dectin-1 expression and induces dectin-1-dependent reactive oxygen species (ROS) generation. Immunobiology 2009; 214(4): 321-30.
16. [16] Vukman KV, Ravida A, Aldridge AM, O'Neill SM. Mannose receptor and macrophage galactose-type lectin are involved in Bordetella pertussis mast cell interaction. J Leukoc Biol 2013; 94(3): 439-48.
17. [17] Fukuda M, Ushio H, Kawasaki J, et al. Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection. J Innate Immun 2013; 5(2): 163-73.
18. [18] Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD. Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol. 2007; 36(1): 43-52.
19. [19] Wu L, Feng BS, He SH, et al. Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2. Immunol Cell Biol 2007; 85(7): 538-45.
20. [20] Nakamura Y, Kambe N, Saito M, et al. Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J Exp Med. 2009; 206(5): 1037-46.
21. [21] Enoksson M, Ejendal KF, McAlpine S, Nilsson G, Lunderius-Andersson C. Human cord blood-derived mast cells are activated by the Nod1 agonist M-TriDAP to release pro-inflammatory cytokines and chemokines. J Innate Immun. 2011; 3(2): 142-9.
22. [22] Applequist SE, Wallin RP, Ljunggren HG. Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines. Int Immunol 2002; 14(9): 1065-74.
23. [23] Matsushima H, Yamada N, Matsue H, Shimada S. TLR3-,TLR7-,and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004; 173(1): 531-41.
24. [24] Woodbury RG, Miller HR, Huntley JF, et al. Mucosal mast cells are functionally active during spontaneous expulsion of intestinal nematode infections in rat. Nature. 1984; 312(5993): 450-2.
25. [25] Romani L, Puccetti P. Immune regulation and tolerance to fungi in the lungs and skin. Chem Immunol Allergy. 2008; 94: 124-37.
26. [26] Romo-Lozano Y, Hernandez-Hernandez F, Salinas E. Mast cell activation by conidia of Sporothrix schenckii: role in the severity of infection. Scand J Immunol 2012; 76(1): 11-20.
27. [27] Urb M, Pouliot P, Gravelat FN, Olivier M, Sheppard DC. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. J Infect Dis. 2009; 200(3): 464-72.
28. [28] Malaviya R, Ikeda T, Ross E, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996; 381(6577): 77-80.
29. [29] Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998; 11(4): 589-603.
30. [30] Sanchez-Vargas FM, Gomez-Duarte OG. Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 2008; 14(2): 105-17.
31. [31] Xu X, Zhang D, Lyubynska N, et al. Mast cells protect mice from Mycoplasma pneumonia. Am J Respir Crit Care Med. 2006; 173(2): 219-25.
32. [32] Ellis J, Oyston PC, Green M, Titball RW. Tularemia. Clin Microbiol Rev. 2002; 15(4): 631-46.
33. [33] Ketavarapu JM, Rodriguez AR, Yu JJ, et al. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc Natl Acad Sci U S A. 2008; 105(27): 9313-9318.
34. [34] Dannenberg AM, Jr. Perspectives on clinical and preclinical testing of new tuberculosis vaccines. Clin Microbiol Rev. 2010; 23(4): 781-94.
35. [35] Taweevisit M, Poumsuk U. High mast cell density associated with granulomatous formation in tuberculous lymphadenitis. Southeast Asian J Trop Med Public Health. 2007; 38(1): 115-9.
36. [36] Munoz S, Hernandez-Pando R, Abraham SN, Enciso JA. Mast cell activation by Mycobacterium tuberculosis: mediator release and role of CD48. J Immunol. 2003; 170(11): 5590-6.
37. [37] Munoz S, Rivas-Santiago B, Enciso JA. Mycobacterium tuberculosis entry into mast cells through cholesterol-rich membrane microdomains. Scand J Immunol 2009; 70(3): 256-63.
38. [38] Carlos D, de Souza Junior DA, de Paula L, et al. Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis. J Infect Dis 2007; 196(9): 1361-8.
39. [39] Carlos D, Frantz FG, Souza-Junior DA, et al. TLR2-dependent mast cell activation contributes to the control of Mycobacterium tuberculosis infection. Microbes Infect 2009; 11(8-9): 770-8.
40. [40] José AG, Jesús CF, Dina VG, et al. Overview of clinical and molecular aspects involved in the development of symptomatic infection and end-organ disease caused by cytomegalovirus in pediatric patients. Cytomegalovirus Infections: Risk Factors, Causes and Management 2012: 293-324.
41. [41] Ebert S, Becker M, Lemmermann NA, et al. Mast cells expedite control of pulmonary murine cytomegalovirus infection by enhancing the recruitment of protective CD8 T cells to the lungs. PLoS Pathog. 2014; 10(4): e1004100.
42. [42] Taubenberger JK, Kash JC. Influenza virus evolution, host adaptation, and pandemic formation. Cell Host Microbe 2010; 7(6): 440-51.
43. [43] Kobasa D, Jones SM, Shinya K, et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007; 445(7125): 319-23.
44. [44] Hu Y, Jin Y, Han D, et al. Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J Virol 2012; 86(6): 3347-56.
45. [45] Graham AC, Hilmer KM, Zickovich JM, Obar JJ. Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling. J Immunol 2013; 190(9): 4676-84.
46. [46] Jolly S, Detilleux J, Desmecht D. Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet Immunol Immunopathol 2004; 97(3-4): 125-36.
47. [47] St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN. Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife 2013; 2: e00481.
48. [48] Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8(10): 1095-104.
49. [49] Chacon-Salinas R, Limon-Flores AY, Chavez-Blanco AD, Gonzalez-Estrada A, Ullrich SE. Mast cell-derived IL-10 suppresses germinal center formation by affecting T follicular helper cell function. J Immunol 2011; 186(1): 25-31.
50. [50] Chacon-Salinas R, Chen L, Chavez-Blanco AD, et al. An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation. J Leukoc Biol 2014; 95(1): 139-148.
51. [51] Chan CY, St John AL, Abraham SN. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity. 2013; 38(2): 349-359.
52. [52] Choi HW, Brooking-Dixon R, Neupane S, et al. Salmonella typhimurium impedes innate immunity with a mast-cell-suppressing protein tyrosine phosphatase, SptP. Immunity. 2013; 39(6): 1108-1120.
53. [53] Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal microbiota. Nat Rev Immunol. 2010; 10(3): 159-169.
54. [54] Zeissig S, Blumberg RS. Life at the beginning: perturbation of the microbiota by antibiotics in early life and its role in health and disease. Nat Immunol. 2014; 15(4): 307-310.
55. [55] Magerl M, Lammel V, Siebenhaar F, et al. Non-pathogenic commensal Escherichia coli bacteria can inhibit degranulation of mast cells. Exp Dermatol. 2008; 17(5): 427-435.
56. [56] Harata G, He F, Takahashi K, et al. Bifidobacterium suppresses IgE-mediated degranulation of rat basophilic leukemia (RBL-2H3) cells. Microbiol Immunol. 2010; 54(1): 54-57.
57. [57] Oksaharju A, Kankainen M, Kekkonen RA, et al. Probiotic Lactobacillus rhamnosus downregulates FCER1 and HRH4 expression in human mast cells. World J Gastroenterol. 2011; 17(6): 750-9.
58. [58] Kalliomaki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357(9262): 1076-9.
59. [59] Schiffer C, Lalanne AI, Cassard L, et al. A strain of Lactobacillus casei inhibits the effector phase of immune inflammation. J Immunol. 2011; 187(5): 2646-55.
60. [60] Sagar S, Morgan ME, Chen S, et al. Bifidobacterium breve and Lactobacillus rhamnosus treatment is as effective as budesonide at reducing inflammation in a murine model for chronic asthma. Respir Res. 2014; 15: 46.
61. [61] Palm NW, Rosenstein RK, Medzhitov R. Allergic host defences. Nature. 2012; 484(7395): 465-72.
62. [62] Barnig C, Cernadas M, Dutile S, et al. Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med. 2013; 5(174): 174ra26.
63. [63] Jung JA, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol. 2010; 125(1): 217-21.
64. [64] Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008; 122(4): 719-23.
65. [65] Baraldo S, Contoli M, Bazzan E, et al. Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma. J Allergy Clin Immunol. 2012; 130(6): 1307-14.
66. [66] Kim YJ, Ryu SL, Jung SH, et al. Increased Prevalence of H1N1-Induced Severe Lower Respiratory Tract Diseases in Children With Atopic Sensitization. Allergy Asthma Immunol Res. 2012; 4(5): 277-83.
67. [67] Rantala A, Jaakkola JJ, Jaakkola MS. Respiratory infections in adults with atopic disease and IgE antibodies to common aeroallergens. PLoS One. 2013; 8(7): e68582.
68. [68] Jung JA, Kita H, Dhillon R, et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med. 2010; 122(5): 116-24.
69. [69] James KM, Peebles RS, Jr., Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol. 2012; 130(2): 343-51.
70. [70] Michels NM, Chu HW, LaFasto SC, et al. Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions. Clin Exp Allergy. 2010; 40(9): 1406-13.
71. [71] Sykes, A. Asthma and infections: An update on asthma exacerbations. Clinical Pulmonary Medicine. 2013; 20(2): 56-60.
72. [72] Dakhama A, Lee YM, Ohnishi H, et al. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol. 2009; 123(1): 138-45 e5.
73. [73] Al-Garawi AA, Fattouh R, Walker TD, et al. Acute, but not resolved, influenza A infection enhances susceptibility to house dust mite-induced allergic disease. J Immunol. 2009; 182(5): 3095-3104.
74. [74] Hosoda M, Yamaya M, Suzuki T, et al. Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J Immunol. 2002; 169(3): 148-291.
75. [75] Calhoun WJ, Dick EC, Schwartz LB, Busse WW. A common cold virus, rhinovirus 16, potentiates airway inflammation after segmental antigen bronchoprovocation in allergic subjects. J Clin Invest. 1994; 94(6): 2200-8.
76. [76] Seggev JS, Sedmak GV, Kurup VP. Isotype-specific antibody responses to acute Mycoplasma pneumoniae infection. Ann Allergy Asthma Immunol. 1996; 77(1): 67-73.
77. [77] Kjaergard LL, Larsen FO, Norn S, et al. Basophil-bound IgE and serum IgE directed against Haemophilus influenzae and Streptococcus pneumoniae in patients with chronic bronchitis during acute exacerbations. APMIS. 1996; 104(1): 61-67.
78. [78] Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis. 1995; 172(1): 265-7.
79. [79] Brzezinska-Blaszczyk E, Wasiela M. Vaginal bacterial flora activates rat peritoneal mast cells. International Journal of Immunopathology and Pharmacology. 2002; 15(3): 233-8.
80. [80] Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS One. 2010; 5(1): e8578.
81. [81] Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010; 89(3): 219-29.
82. [82] Azevedo LH, De Sousa SCOM, Correa L, et al. Mast cell concentration in the wound healing process of incisions made by different instruments. Lasers in Medical Science. 2009; 24(4): 585-590.
83. [83] Lazaar AL, Plotnick MI, Kucich U, et al. Mast cell chymase modifies cell-matrix interactions and inhibits mitogen-induced proliferation of human airway smooth muscle cells. J Immunol. 2002; 169(2): 1014-20.
84. [84] Fajardo I, Pejler G. Human mast cell beta-tryptase is a gelatinase. J Immunol. 2003; 171(3): 1493-9.
85. [85] Abe M, Kurosawa M, Ishikawa O, Miyachi Y. Effect of mast cell-derived mediators and mast cell-related neutral proteases on human dermal fibroblast proliferation and type I collagen production. J Allergy Clin Immunol. 2000; 106(1 Pt 2): S78-84.
86. [86] Shiota N, Nishikori Y, Kakizoe E, et al. Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int Arch Allergy Immunol. 2010; 151(1): 80-8.
87. [87] Kankkunen JP, Harvima IT, Naukkarinen A. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions. Int J Cancer. 1997; 72(3): 385-8.
88. [88] Duncan LM, Richards LA, Mihm MC, Jr. Increased mast cell density in invasive melanoma. J Cutan Pathol. 1998; 25(1): 11-5.
89. [89] Molin D, Edstrom A, Glimelius I, et al. Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma. Br J Haematol. 2002; 119(1): 122-4.
90. [90] Iamaroon A, Pongsiriwet S, Jittidecharaks S, et al. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med. 2003; 32(4): 195-9.
91. [91] Tuna B, Yorukoglu K, Unlu M, Mungan MU, Kirkali Z. Association of mast cells with microvessel density in renal cell carcinomas. Eur Urol. 2006; 50(3): 530-4.
92. [92] Ribatti D, Finato N, Crivellato E, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol. 2005; 193(6): 1961-5.
93. [93] Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem. 2001; 49(8): 1061-2.
94. [94] Imada A, Shijubo N, Kojima H, Abe S. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Respir J. 2000; 15(6): 1087-93.
95. [95] Huang B, Lei Z, Zhang GM, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood. 2008; 112(4): 1269-79.
96. [96] Galinsky DS, Nechushtan H. Mast cells and cancer--no longer just basic science. Crit Rev Oncol Hematol. 2008; 68(2): 115-30.
97. [97] Stoyanov E, Uddin M, Mankuta D, Dubinett SM, Levi-Schaffer F. Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. Lung Cancer. 2012; 75(1): 38-44.
98. [98] Zudaire E, Martinez A, Garayoa M, et al. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol. 2006; 168(1): 280-91.
99. [99] Welsh TJ, Green RH, Richardson D, et al. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 2005; 23(35): 8959-67.